scispace - formally typeset
Open AccessJournal ArticleDOI

Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol.

TLDR
Distinct plasma ceramide ratios are significant predictors of CV death both in patients with stable CAD and ACS, over and above currently used lipid markers.
Abstract
All authors:Reijo Laaksonen, Kim Ekroos, Marko Sysi-Aho, Mika Hilvo, Terhi Vihervaara, Dimple Kauhanen, Matti Suoniemi, Reini Hurme, Winfried Marz, Hubert Scharnagl, Tatjana Stojakovic, Efthymia Vlachopoulou, Marja-Liisa Lokki, Markku S. Nieminen, Roland Klingenberg, Christian M. Matter, Thorsten Hornemann, Peter Juni, Nicolas Rodondi, Lorenz Raber, Stephan Windecker, Baris Gencer, Eva Ringdal Pedersen, Grethe S. Tell, Ottar Nygard, Francois Mach, Juha Sinisalo, Thomas F. Lusche

read more

Citations
More filters
Journal ArticleDOI

Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort.

TL;DR: Distinct serum ceramides are associated with the risk of incident MACE in apparently healthy individuals and should encourage more detailed analyses of ceramide in cardiovascular pathobiology and suggest new biomarkers of MACE risk.
Journal ArticleDOI

High-Throughput Plasma Lipidomics: Detailed Mapping of the Associations with Cardiometabolic Risk Factors.

TL;DR: A chromatography gradient coupled with a detailed characterization of the human plasma lipidome is reported to provide improved resolution and identification of 636 lipid species, including previously unreported species, in a 15-min analysis.
References
More filters
Journal ArticleDOI

Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond

TL;DR: Two new measures, one based on integrated sensitivity and specificity and the other on reclassification tables, are introduced that offer incremental information over the AUC and are proposed to be considered in addition to the A UC when assessing the performance of newer biomarkers.
Journal ArticleDOI

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

TL;DR: The If Inhibitor Ivabradine in Patients With Coronary Artery Disease and Left Ventricular Dysfunction is evaluated as well as patients with Diabetes mellitus for Optimal management of Multivessel disease.
Journal ArticleDOI

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

TL;DR: This paper presents a Randomized Assessment of Acute Coronary Syndrome Treatment of Intracoronary Stenting With Antithrombotic Regimen and Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction.
Related Papers (5)